欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FR/H/0419/005
药品名称
PERIOLIMEL N4E
活性成分
glucose 0.0 00
剂型
Emulsion for infusion
上市许可持有人
BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Germany (DE)
Olimel Peri 2,5% E Emulsion zur Infusion
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion
Spain (ES)
Italy (IT)
Greece (GR)
OLIMEL
Slovenia (SI)
Slovakia (SK)
OLIMEL PERI N4E
Bulgaria (BG)
Cyprus (CY)
OLIMEL PERI N4E EMULSION FOR INFUSION
Lithuania (LT)
OLIMEL PERI N4E infuzinė emulsija
Czechia (CZ)
PERIOLIMEL N4E
Latvia (LV)
Malta (MT)
Estonia (EE)
Norway (NO)
Poland (PL)
Olimel N7
Finland (FI)
Hungary (HU)
OLIMEL 9 g/l nitrogén elektrolitokkal emulziós infúzió
Romania (RO)
OLIMEL N9
Sweden (SE)
Portugal (PT)
许可日期
2009/10/23
最近更新日期
2024/03/04
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Non Prescription (including OTC)
附件文件下载
Final Product Information
|
common-spc-cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2014/01/09
Final Product Information
|
common-pl-cleanconsolidatedR1 with RMS additional recommended changes
Date of last change:2014/01/09
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase